1. Report Introduction
2. Hidradenitis Suppurativa Epidemiology Overview at a Glance
3. Market Share Distribution of Hidradenitis Suppurativa
4. Disease Background and Overview: Hidradenitis Suppurativa
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Hidradenitis Suppurativa Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Hidradenitis Suppurativa by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
7.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
7.4. Sex- Specific Cases of Hidradenitis Suppurativa*
7.5. Diagnosed Cases of Hidradenitis Suppurativa
7.6. Treated Cases of Hidradenitis Suppurativa
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
8.1.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
8.1.4. Sex- Specific Cases of Hidradenitis Suppurativa*
8.1.5. Diagnosed Cases of Hidradenitis Suppurativa
8.1.6. Treated Cases of Hidradenitis Suppurativa
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
8.2.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
8.2.4. Sex- Specific Cases of Hidradenitis Suppurativa*
8.2.5. Diagnosed Cases of Hidradenitis Suppurativa
8.2.6. Treated Cases of Hidradenitis Suppurativa
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
8.3.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
8.3.4. Sex- Specific Cases of Hidradenitis Suppurativa*
8.3.5. Diagnosed Cases of Hidradenitis Suppurativa
8.3.6. Treated Cases of Hidradenitis Suppurativa
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
8.4.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
8.4.4. Sex- Specific Cases of Hidradenitis Suppurativa*
8.4.5. Diagnosed Cases of Hidradenitis Suppurativa
8.4.6. Treated Cases of Hidradenitis Suppurativa
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
8.5.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
8.5.4. Sex- Specific Cases of Hidradenitis Suppurativa*
8.5.5. Diagnosed Cases of Hidradenitis Suppurativa
8.5.6. Treated Cases of Hidradenitis Suppurativa
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Hidradenitis Suppurativa
9.3. Sub-Type Specific cases of Hidradenitis Suppurativa*
9.4. Sex- Specific Cases of Hidradenitis Suppurativa*
9.5. Diagnosed Cases of Hidradenitis Suppurativa
9.6. Treated Cases of Hidradenitis Suppurativa
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.